Gilead Sciences, Inc.
Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%
Gilead Sciences Total non-GAAP adjustments to costs and expenses by Year
Total non-GAAP adjustments to costs and expenses ($M) ($M)
Gilead Sciences Total non-GAAP adjustments to costs and expenses: $3,171M in FY2025, down 53.8% from a year earlier.
Where the FY2025 figure comes from
“|| Total non-GAAP adjustments to costs and expenses | 1,104 | 663 | 3,171 | 6,858”
Source: Form 8-K (exhibit991earningspressrel.htm, filed 2026-02-10) ↗
Reported in Form 8-K Non-GAAP Adjustment Summary.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total non-GAAP adjustments to costs and expenses ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3,171 | -53.8% | Form 8-K (exhibit991earningspressrel.htm, filed 2026-02-10) ↗ |
| FY2024 | Dec 31, 2024 | 6,858 | +138.2% | Form 8-K (exhibit991earningspressrel.htm, filed 2026-02-10) ↗ |
| FY2023 | Dec 31, 2023 | 2,879 | -40.6% | Form 8-K (exhibit991earningspressrel.htm, filed 2025-02-11) ↗ |
| FY2022 | Dec 31, 2022 | 4,850 | – | Form 8-K (exhibit991earningspressrel.htm, filed 2024-02-06) ↗ |
Cite this data
StockData. (2026). Gilead Sciences Total non-GAAP adjustments to costs and expenses ($M), annual FY2022–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/ng-adj-opex
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.